News | News By Subject | News by Disease News By Date | Search News

News By Date

Get Our FREE
Industry eNewsletter
email:    
News By Date

SuMoTuWeThFrSa
31123456
78910111213
14151617181920
21222324252627
2829301234
567891011

Friday, September 19, 2014

Top Breaking News
Takeda Pharmaceutical Co. Ltd. (TKPYY) Backs Weight Loss Drug Contrave With 900 Sales Reps
Allozyne, Inc. Sold For Scrap As MedImmune (AZN) Snaps Up Rights
Eli Lilly and Company (LLY) Gets Thumbs Up From FDA For Diabetes Drug Trulicity
Health Canada Requests Quarantine Of Ipca Laboratories' Products Following Falsification And Manipulation Of Data Issues
Chinese Court Hits GlaxoSmithKline (GSK) With $492M Bribery Fine
60 Percent Of New York’s Hep C Patients Will Get Gilead Sciences, Inc. (GILD)'s Sovaldi
GlaxoSmithKline (GSK) Will End Promotional Pay To Doctors
FDA Panel Denies Clarus Therapeutics' Oral Testosterone Drug Rextoro
Horizon Pharma plc.  (HZNP) Moves To Ireland As Frustrated Lawmakers Look On
Soligenix (SNGX) Awarded National Institute of Allergy And Infectious Diseases (NIAID) Contract Valued Up To $24.7 Million
Natco Pharma Limited, Orchid Chemicals Hit With A Strong Dose Of FDA Medicine
AmpliPhi Biosciences Corporation (APHB) Announces Departure Of CEO

Featured Stories

More News
European Commission Grants Marketing Authorization For Gilead Sciences, Inc. (GILD)’s Zydelig® (Idelalisib) For The Treatment Of Chronic Lymphocytic Leukemia And Follicular Lymphoma
Transparency Life Sciences To Conduct Sarcoidosis Trial For Auven Therapeutics' Kiacta™ Using Crowdsourcing And Telemonitoring
BioTime (BTX) Announces Presentation Of Phase 3 Data At EASD Showing ITCA 650 Markedly Reduces Blood Sugar In Patients With Poorly Controlled Type 2 Diabetes
Umecrine Mood Announces Positive Results From An Exploratory Phase I/II Study With UC1010 In Premenstrual Dysphoric Disorder (PMDD)
Alexion Pharmaceuticals Inc. (ALXN) Release: Paediatric Patients With Hypophosphatasia Receiving Investigational Asfotase Alfa Had Sustained Improvements In Growth And Physical Function
DNAtrix, Inc. Announces Treatment Of First Patient With DNX-2401 In Recurrent Glioblastoma Trial
Nektar Therapeutics (CA) (NKTR) Presents Positive Preclinical Data On Oral, Peripherally-Acting Kappa Agonist Molecules At 2014 American Academy Of Pain Management Meeting
Pressure BioSciences, Inc. (BBII) Announces Completion Of The First Phase Of Its Commercialization Plan For The Barozyme HT48, The Company's Recently Released High Throughput PCT-Based Instrument System
Eisai Company, Ltd. (ESALY.PK) Release: Plasmacluster Ion Technology Reduced Airway Inflammation In Pediatric Patients With Mild To Moderate Atopic Asthma
The George Institute for Global Health Release: ADVANCE-ON Post-Trial Observational Study: Blood Pressure Arm And Glucose Arm Results
Haukeland University Hospital Release: Pilot Study Shows Promise for Treatment of Pancreatic Cancer
PCI Significantly Expands Global Clinical Services Business Through Biotec Acquisition
BioTie Therapies Corp.: Selincro Enters The Market In France
Swedish Orphan Biovitrum Expands Haemophilia Development Portfolio - Elects To Include Potentially Longer-Acting Haemophilia A Candidate In Collaboration Agreement With Biogen Idec, Inc. (Massachusetts) (BIIB)
Crowdsourcing Collaboration Celebrates “Outside The Box” Applications For The Dow Chemical Company (DOW)’s UCON™ Oil Soluble Pags To Help Address Global Challenges
EMD Group (EMD Millipore (Massachusetts)) Awards Grant For Growth Innovation (GGI) For The First Time
Kymab Succeeds In Revoking Regeneron Pharmaceuticals, Inc. (REGN)’s European Patent
Recipharm AB Secures Financing For Continued Growth
ICON Plc Announces Completion Of $40 Million Share Buyback And A Further Share Buyback Program For Up To $100 Million
Lpath, Inc. (LPTN) Announces $12.5 Million Registered Direct Offering
PharMerica Announces New Senior Secured Credit Agreement
Aratana Therapeutics (PETX) Announces Full Exercise Of Underwriters' Option To Purchase Additional Shares
Alexza Pharmaceuticals, Inc. (ALXA) And Ferrer Internacional Provide Update On ADASUVE® European Commercial Activities
DiaGenic ASA – Notice Of Extraordinary General Meeting
Tenax Therapeutics To Provide Corporate Update And Discuss First Quarter Fiscal Year 2015 Financial Results On September 24, 2014
Celgene (CELG) Appoints Tuomo Pätsi As President Of EMEA And Commits To Continue Delivering Innovative Solutions To Meet Patient Needs Across The Region
Mary Tanner Appointed To Genticel’s Supervisory Board As Independently-Acting Member
Ocera Therapeutics, Inc. (OCRX) Announces Appointment Of Steven P. James To Board
Alere Inc. (ALR) Applauds President's Executive Order Combating Antibiotic-Resistant Bacteria
Cloud Pharmaceuticals Announces Partnering Sessions And Presentation Schedule
CytRx Corporation (CYTR) To Present At Biocentury's 2014 Newsmakers In The Biotech Industry Conference
Pfenex Inc. (PFNX) To Present At Upcoming Industry Conference On September 26
Merrimack Pharmaceuticals Inc. (MACK)To Present Clinical And Biomarker Data On Novel Antibody Therapeutics At The ESMO 2014 Congress
BioSpecifics Technologies Corporation (BSTC) Announces New MULTICORD And Retreatment Data For XIAFLEX® For Dupuytren's Contracture Presented At American Society For Surgery Of The Hand Annual Meeting
Biotechnology Industry Organization (BIO) Announces Breakout Program Speakers For Pacific Rim Summit On Industrial Biotechnology
Genocea Biosciences To Present At The 21st Annual NewsMakers In The Biotech Industry Conference
BioSpecifics Technologies Corporation (BSTC) To Present At The 21st Annual Biocentury Newsmakers In The Biotech Industry Conference
Celator Pharmaceuticals, Inc. To Present At Biocentury's 21st Annual Newsmakers In The Biotech Industry Conference
Argos Therapeutics, Inc. (ARGS) To Present At The 21st Annual Biocentury Newsmakers Conference
Cyclacel Pharmaceuticals, Inc. (CYCC) To Present At Biocentury's Newsmakers In The Biotech Industry Conference
TONIX Pharmaceuticals, Inc. To Present At The Biocentury Newsmakers Conference

//-->